fbpx

Life+News The Official News Portal of Independent Television Network Ltd

Modified polio vaccine extends lives in U.S. brain cancer study

ITN News Editor
By ITN News Editor June 27, 2018 19:18

Modified polio vaccine extends lives in U.S. brain cancer study

Some 21 percent of patients with advanced brain cancer treated with a modified polio vaccine were alive after three years, compared with 4 percent of patients with similar tumours who received standard therapies. The findings, published online in the New England Journal of Medicine, are the latest update on an experimental cancer vaccine developed at Duke Cancer Institute in Durham, North Carolina, for patients with glioblastoma, a deadly form of brain cancer. For most patients whose glioblastoma has recurred after treatment, the average survival is 12 months. Treatment typically involves a mix of surgery, chemotherapy, radiation and targeted treatments.

ITN News Editor
By ITN News Editor June 27, 2018 19:18